News / Clinical Trials

Spero Therapeutics and GSK's Oral UTI Treatment Shows Promising Results

Spero Therapeutics and GSK have announced positive results from their Phase 3 PIVOT-PO trial evaluating tebipenem HBr, an investigational oral treatment for complicated urinary tract infections (cUTIs). The trial was stopped early due to ef...